This investigation pinpointed TSPAN15, TSPAN9, and TSPAN16 as signature genes associated with TM4SF in ESCC, and crafted an innovative predictive model capable of accurately forecasting the outcomes for patients with ESCC, while clarifying their significant roles in the ESCC tumor immune microenvironment. Here, TSPAN16 is linked to neoplasm.